Obesity
Guidance for Practicing Primary Care
Addressing obesity bias in health care
No one should feel stigmatized when they come for medical help.
Latest News
Docs weigh in on insurance coverage for obesity medications
“We would not see the spate of coverage restrictions if we were talking about heart disease or cancer; insurers can get away with this because...
From the Journals
Scientists find the ‘on’ switch for energy-burning brown fat
Activating brown fat could trigger “signals that help coordinate whole-body energy metabolism.”
From the Journals
Metformin, weight management to stop type 2 diabetes in kids
“Weight stabilization and metformin therapy could be important interventions for diabetes prevention in children.”
Conference Coverage
New ‘twincretin’ pemvidutide: Another option for obesity
“We need to look at the person holistically and at other aspects of cardiometabolic health and treat in a personalized way and choose treatments...
Latest News
Roflumilast side effect benefits patients with psoriasis and overweight/obesity
An “extraordinary” finding was how some patients’ weight status based on their BMI changed throughout the study.
Conference Coverage
Obesity linked to multiple ills in MS study
Subjects with excess weight progressed more rapidly and had more cognitive disability.
Conference Coverage
Are they ‘antiobesity medications’ or ‘weight-loss drugs’?
“We believe that the common use of the term ‘weight-loss medications’ by media and the public, as well as by doctors and the scientific community...
Applied Evidence
Inadequate sleep & obesity: Breaking the vicious cycle
Poor sleep negatively affects hormones that govern the food reward system and can interfere with weight-loss programs. Obesity in turn restricts...
Feature
The new word in liver disease: The story behind NAFLD’s rebranding as MASLD
“There are tons of these patients who were not being considered before. Now they’re in a category by themselves, where they are going to be able...
Conference Coverage
Weight loss with semaglutide maintained for up to 3 years
“Importantly, these effects were sustained for up to 3 years, supporting the use of once weekly semaglutide for the long-term management of type 2...